{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T03:14:21Z","timestamp":1772248461950,"version":"3.50.1"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T00:00:00Z","timestamp":1575331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2019.02790","type":"journal-article","created":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T23:27:50Z","timestamp":1575329270000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Omeprazole Increases the Efficacy of Acyclovir Against Herpes Simplex Virus Type 1 and 2"],"prefix":"10.3389","volume":"10","author":[{"given":"Martin","family":"Michaelis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malte C.","family":"Kleinschmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denisa","family":"Bojkova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holger F.","family":"Rabenau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark N.","family":"Wass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jindrich","family":"Cinatl Jr.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,12,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.293","article-title":"Targeting endosomal acidification by chloroquine analogs as a promising strategy for the treatment of emerging viral diseases.","volume":"5","author":"Al-Bari","year":"2017","journal-title":"Pharmacol. Res. Perspect."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.218","article-title":"Proton pump inhibitors protect mice from acute systemic inflammation and induce long-term cross-tolerance.","volume":"7","author":"Balza","year":"2016","journal-title":"Cell Death Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1586\/erv.09.19","article-title":"Vero cell platform in vaccine production: moving towards cell culture-based viral vaccines.","volume":"8","author":"Barrett","year":"2009","journal-title":"Expert Rev. Vaccines."},{"key":"B4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.coviro.2014.04.011","article-title":"Ribavirin: a drug active against many viruses with multiple effects on virus replication and propagation. Molecular basis of ribavirin resistance.","volume":"8","author":"Beaucourt","year":"2014","journal-title":"Curr. Opin. Virol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1083\/jcb.106.3.761","article-title":"Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line.","volume":"106","author":"Boukamp","year":"1988","journal-title":"J. Cell Biol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.antiviral.2018.05.005","article-title":"Innovation and trends in the development and approval of antiviral medicines: 1987-2017 and beyond.","volume":"155","author":"Chaudhuri","year":"2018","journal-title":"Antiviral Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.antiviral.2019.01.008","article-title":"In vitro comparison of currently available and investigational antiviral agents against pathogenic human double-stranded DNA viruses: a systematic literature review.","volume":"163","author":"Chemaly","year":"2019","journal-title":"Antiviral Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/jop.12534","article-title":"Efficacy and safety of nucleoside antiviral drugs for treatment of recurrent herpes labialis: a systematic review and meta-analysis.","volume":"46","author":"Chen","year":"2017","journal-title":"J. Oral. Pathol. Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.antiviral.2005.04.002","article-title":"Error-prone replication of West Nile virus caused by ribavirin.","volume":"67","author":"Day","year":"2005","journal-title":"Antiviral Res."},{"key":"B10","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1128\/JVI.2.10.955-961.1968","article-title":"Defectiveness of interferon production and of rubella virus interference in a line of African green monkey kidney cells (Vero).","volume":"2","author":"Desmyter","year":"1968","journal-title":"J. Virol."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-22620-22622","article-title":"Antiviral effect of Ribavirin against HCV associated with increased frequency of G-to-A and C-to-U transitions in infectious cell culture model.","volume":"8","author":"Galli","year":"2018","journal-title":"Sci. Rep."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00499","article-title":"Proton pump inhibitors in IPF: a call for clinical trials.","volume":"9","author":"Ghebre","year":"2018","journal-title":"Front. Pharmacol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1056\/NEJMcp1603178","article-title":"Clinical practice.","volume":"375","author":"Gnann","year":"2016","journal-title":"Genital. Herpes. N. Engl. J. Med."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010684.pub2","article-title":"Interventions for men and women with their first episode of genital herpes.","volume":"8","author":"Heslop","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00911","article-title":"Drug repositioning of proton pump inhibitors for enhanced efficacy and safety of cancer chemotherapy.","volume":"8","author":"Ikemura","year":"2017","journal-title":"Front. Pharmacol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/nrmicro2559","article-title":"Herpesviruses remodel host membranes for virus egress.","volume":"9","author":"Johnson","year":"2011","journal-title":"Nat. Rev. Microbiol."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1177\/2040206618764483","article-title":"Nucleosides for the treatment of respiratory RNA virus infections.","volume":"26","author":"Jordan","year":"2018","journal-title":"Antivir. Chem. Chemother."},{"key":"B18","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1007\/bf01863914","article-title":"Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche [A contribution to the collective treatment of a pharmacological experimental series].","volume":"162","author":"K\u00e4rber","year":"1931","journal-title":"Archiv. f\u00fcr Experimentelle Pathologie und Pharmakologie"},{"key":"B19","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jns.2017.11.024","article-title":"Rapid acquisition of acyclovir resistance in an immunodeficient patient with herpes simplex encephalitis.","volume":"384","author":"Karrasch","year":"2018","journal-title":"J. Neurol. Sci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.antiviral.2018.12.017","article-title":"Ribavirin induces widespread accumulation of IMP dehydrogenase into rods\/rings structures in multiple major mouse organs.","volume":"162","author":"Keppeke","year":"2019","journal-title":"Antiviral. Res."},{"key":"B21","doi-asserted-by":"crossref","DOI":"10.2174\/0929867325666180309105519","article-title":"Acyclovir in the treatment of Herpes viruses - a review.","author":"Klysik","year":"2018","journal-title":"Curr. Med. Chem."},{"key":"B22","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.antiviral.2014.01.005","article-title":"What is the future of ribavirin therapy for hepatitis C?","volume":"104","author":"Koh","year":"2014","journal-title":"Antiviral Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/0042-6822(84)90356-8","article-title":"Inhibition of multiplication of herpes simplex virus type 1 by ammonium chloride and chloroquine.","volume":"138","author":"Koyama","year":"1984","journal-title":"Virology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0168-1702(89)90073-7","article-title":"The effect of ammonium chloride on the multiplication of herpes simplex virus type 1 in Vero cells.","volume":"13","author":"Koyama","year":"1989","journal-title":"Virus Res."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000008120","article-title":"Comparative effectiveness and acceptability of the FDA-licensed proton pump inhibitors for erosive esophagitis: a PRISMA-compliant network meta-analysis.","volume":"96","author":"Li","year":"2017","journal-title":"Medicine"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1093\/jnci\/djh305","article-title":"Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs.","volume":"96","author":"Luciani","year":"2004","journal-title":"J. Natl. Cancer Inst."},{"key":"B27","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/s0300-483x(98)00101-2","article-title":"Evaluation of omeprazole genotoxicity in a battery of in vitro and in vivo assays.","volume":"130","author":"Martelli","year":"1998","journal-title":"Toxicology"},{"key":"B28","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1093\/jac\/dkm307","article-title":"Minocycline inhibits West Nile virus replication and apoptosis in human neuronal cells.","volume":"60","author":"Michaelis","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"key":"B29","first-page":"119","article-title":"Experience with the Vero cell line.","volume":"93","author":"Montagnon","year":"1998","journal-title":"Dev. Biol. Stand."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00016","article-title":"Therapeutic efficacy of Esomeprazole in cotton smoke-induced lung injury model.","volume":"8","author":"Nelson","year":"2017","journal-title":"Front. Pharmacol."},{"key":"B31","first-page":"5","article-title":"Recent approval of Xerese in Canada: 5% acyclovir and 1% hydrocortisone topical cream in the treatment of herpes labialis.","volume":"19","author":"Nguyen","year":"2014","journal-title":"Skin Therapy Lett."},{"key":"B32","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1097\/qco.0000000000000288","article-title":"Antiviral resistance in herpes simplex virus and varicella-zoster virus infections: diagnosis and management.","volume":"29","author":"Piret","year":"2016","journal-title":"Curr. Opin. Infect. Dis."},{"key":"B33","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1080\/14787210.2017.1305888","article-title":"Antiviral activity of cationic amphiphilic drugs.","volume":"15","author":"Salata","year":"2017","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"B34","doi-asserted-by":"publisher","first-page":"25","DOI":"10.5056\/jnm.2013.19.1.25","article-title":"Pharmacokinetics and pharmacodynamics of the proton pump inhibitors.","volume":"19","author":"Shin","year":"2013","journal-title":"J. Neurogastroenterol. Motil."},{"key":"B35","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1126\/science.177.4050.705","article-title":"Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide.","volume":"177","author":"Sidwell","year":"1972","journal-title":"Science"},{"key":"B36","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/j.2044-8295.1908.tb00176.x","article-title":"The method of \u201cright and wrong cases\u201d (\u201cconstantstimuli\u201d) without Gauss\u2019s formulae.","volume":"2","author":"Spearman","year":"1908","journal-title":"Br. J. Psychol."},{"key":"B37","first-page":"1201","article-title":"Studies on SV40 in tissue culture-preliminary step for cancer research in vitro.","volume":"21","author":"Yasumura","year":"1963","journal-title":"Nihon Rinsho"},{"key":"B38","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.virusres.2017.01.019","article-title":"Herpesvirus DNA polymerases: structures, functions and inhibitors.","volume":"234","author":"Zarrouk","year":"2017","journal-title":"Virus Res."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2019.02790\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T20:34:23Z","timestamp":1612902863000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2019.02790\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,3]]},"references-count":38,"alternative-id":["10.3389\/fmicb.2019.02790"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2019.02790","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/313072","asserted-by":"object"}]},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,3]]},"article-number":"2790"}}